{
    "nct_id": "NCT06281925",
    "official_title": "A Phase II Randomized Interventional Pilot Study for Colon Cancer Patients Receiving Oxaliplatin: Benefits of Cryotherapy in Prevention of Peripheral Neuropathy",
    "inclusion_criteria": "* Over the age of 18 years\n* Willingness to participate in research\n* Diagnosed with stage III colon cancer\n* Chemotherapy naÃ¯ve\n* Planning to initiate Capecitabine + Oxaliplatin (CAPOX) chemotherapy regimen as part of standard of care.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Pre-existing peripheral neuropathy\n* Pre-existing diabetes\n* Raynaud's disease\n* Metabolic syndrome, including: Hypertension; Hypercholesterolemia; and Obesity (BSA > 2)\n* Upper extremity amputees\n* Specific autoimmune diseases: Guillain-Barre; Lupus; Rheumatoid arthritis; and Sjogren's syndrome",
    "miscellaneous_criteria": ""
}